{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:34:01Z","timestamp":1794580441062,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":15,"publisher":"Springer New York","isbn-type":[{"value":"9781493989034","type":"print"},{"value":"9781493989041","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T00:00:00Z","timestamp":1541808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8904-1_18","type":"book-chapter","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T07:26:35Z","timestamp":1541748395000},"page":"247-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva"],"prefix":"10.1007","author":[{"given":"Salin A.","family":"Chakkalakal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,10]]},"reference":[{"issue":"9","key":"18_CR1","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1200\/jco.2005.02.047","volume":"23","author":"RL Elliott","year":"2005","unstructured":"Elliott RL, Blobe GC (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23(9):2078\u20132093. \nhttps:\/\/doi.org\/10.1200\/jco.2005.02.047","journal-title":"J Clin Oncol"},{"issue":"46","key":"18_CR2","doi-asserted-by":"publisher","first-page":"13057","DOI":"10.1073\/pnas.1603668113","volume":"113","author":"Y Hayashi","year":"2016","unstructured":"Hayashi Y, Hsiao EC, Sami S, Lancero M, Schlieve CR, Nguyen T, Yano K, Nagahashi A, Ikeya M, Matsumoto Y, Nishimura K, Fukuda A, Hisatake K, Tomoda K, Asaka I, Toguchida J, Conklin BR, Yamanaka S (2016) BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16\/INK4A-dependent senescence. Proc Natl Acad Sci U S A 113(46):13057\u201313062","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"18_CR3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1046\/j.1365-2443.2002.00599.x","volume":"7","author":"K Miyazawa","year":"2002","unstructured":"Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7(12):1191\u20131204","journal-title":"Genes Cells"},{"issue":"1","key":"18_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2008.323","volume":"19","author":"T Watabe","year":"2009","unstructured":"Watabe T, Miyazono K (2009) Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 19(1):103\u2013115","journal-title":"Cell Res"},{"issue":"3","key":"18_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","volume":"16","author":"MY Wu","year":"2009","unstructured":"Wu MY, Hill CS (2009) Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell 16(3):329\u2013343","journal-title":"Dev Cell"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/boneres.2016.9","volume":"4","author":"M Wu","year":"2016","unstructured":"Wu M, Chen G, Li YP (2016) TGF-\u03b2 and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res 4:16009. \nhttps:\/\/doi.org\/10.1038\/boneres.2016.9","journal-title":"Bone Res"},{"issue":"3","key":"18_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/humu.20868","volume":"30","author":"FS Kaplan","year":"2009","unstructured":"Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gillessen-Kaesbach G, Hoover-Fong J, Koster B, Pauli RM, Reardon W, Zaidi S-A, Zasloff M, Morhart R, Mundlos S, Groppe J, Shore EM (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 30(3):379\u2013390","journal-title":"Hum Mutat"},{"issue":"5","key":"18_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu MQ, Feldman GJ, Fenstermacher DA, Cho T-J, Choi IH, Connor JM, Delai P, Glaser DL, Le Merrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38(5):525\u2013527","journal-title":"Nat Genet"},{"issue":"9","key":"18_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrrheum.2010.122","volume":"6","author":"EM Shore","year":"2010","unstructured":"Shore EM, Kaplan FS (2010) Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol 6(9):518\u2013527. \nhttps:\/\/doi.org\/10.1038\/nrrheum.2010.122","journal-title":"Nat Rev Rheumatol"},{"issue":"3\u20134","key":"18_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1385\/BMM:3:3-4:261","volume":"3","author":"RJ Pignolo","year":"2005","unstructured":"Pignolo RJ, Foley KL (2005) Nonhereditary heterotopic ossification. Clin Rev Bone Miner Metab 3(3\u20134):261\u2013266","journal-title":"Clin Rev Bone Miner Metab"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/BOT.0000000000000666","volume":"30","author":"DS Edwards","year":"2016","unstructured":"Edwards DS, Kuhn KM, Potter BK, Forsberg JA (2016) Heterotopic ossification: a review of current understanding, treatment, and future. J Orthop Trauma 30:S27\u2013S30","journal-title":"J Orthop Trauma"},{"issue":"8","key":"18_CR12","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/jbmr.1637","volume":"27","author":"SA Chakkalakal","year":"2012","unstructured":"Chakkalakal SA, Zhang DY, Culbert AL, Convente MR, Caron RJ, Wright AC, Maidment ADA, Kaplan FS, Shore EM (2012) An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res 27(8):1746\u20131756. \nhttps:\/\/doi.org\/10.1002\/jbmr.1637","journal-title":"J Bone Miner Res"},{"issue":"9","key":"18_CR13","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/jbmr.2820","volume":"31","author":"SA Chakkalakal","year":"2016","unstructured":"Chakkalakal SA, Uchibe K, Convente MR, Zhang DY, Economides AN, Kaplan FS, Pacifici M, Iwamoto M, Shore EM (2016) Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) fibrodysplasia ossificans progressiva (FOP) mutation. J Bone Miner Res 31(9):1666\u20131675. \nhttps:\/\/doi.org\/10.1002\/jbmr.2820","journal-title":"J Bone Miner Res"},{"issue":"303","key":"18_CR14","doi-asserted-by":"publisher","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","volume":"7","author":"Sarah J. Hatsell","year":"2015","unstructured":"Hatsell SJ, Idone V, Wolken DMA, Huang L, Kim HJ, Wang LL, Wen XL, Nannuru KC, Jimenez J, Xie LQ, Das N, Makhoul G, Chernomorsky R, D'Ambrosio D, Corpina RA, Schoenherr CJ, Feeley K, Yu PB, Yancopoulos GD, Murphy AJ, Economides AN (2015) ACVR1(R206H) receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci Transl Med 7(303). \nhttps:\/\/doi.org\/10.1126\/scitranslmed.aac4358","journal-title":"Science Translational Medicine"},{"issue":"10","key":"18_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/35093537","volume":"2","author":"M Lewandoski","year":"2001","unstructured":"Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2(10):743\u2013755. \nhttps:\/\/doi.org\/10.1038\/35093537","journal-title":"Nat Rev Genet"}],"container-title":["Methods in Molecular Biology","Bone Morphogenetic Proteins"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8904-1_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T07:28:25Z","timestamp":1541748505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8904-1_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,10]]},"ISBN":["9781493989034","9781493989041"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8904-1_18","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-8904-1","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,10]]}}}